SEC 13F Intelligence

Norinchukin Bank, The / ABBV

Norinchukin Bank, The’s Abbvie Inc Position

Does Norinchukin Bank, The own Abbvie Inc (ABBV)? Yes108.0K shares worth $23M (+0.27% of its 13F portfolio) as of Q1 2026, up from 108.0K shares the prior filed quarter.

Position Value
$23M
Q1 2026
Shares
108.0K
% of Portfolio
+0.27%
Quarters Held
30
currently held

Position History ABBV

Reported value by quarter
Q4 ’18: $33MQ4 ’18Q1 ’19: $29MQ2 ’19: $18MQ3 ’19: $20MQ4 ’19: $21MQ4 ’19Q1 ’20: $10MQ2 ’20: $14MQ3 ’20: $13MQ4 ’20: $15MQ4 ’20Q1 ’21: $16MQ2 ’21: $16MQ3 ’21: $16MQ4 ’21: $21MQ4 ’21Q1 ’22: $27MQ2 ’22: $19MQ3 ’22: $19MQ4 ’22: $18MQ4 ’22Q1 ’23: $18MQ2 ’23: $21MQ3 ’23: $10MQ4 ’23: $10MQ4 ’23Q1 ’24: $11MQ2 ’24: $11MQ3 ’24: $14MQ4 ’24: $14MQ4 ’24Q1 ’25: $19MQ2 ’25: $18MQ3 ’25: $23MQ4 ’25: $25MQ4 ’25Q1 ’26: $23Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 2026108.0K$23M+0.27%
Q4 2025108.0K$25M+0.29%
Q3 2025100.9K$23M+0.31%
Q2 202598.9K$18M+0.27%
Q1 202592.0K$19M+0.35%
Q4 202479.8K$14M+0.30%
Q3 202472.9K$14M+0.34%
Q2 202462.6K$11M+0.31%
Q1 202461.9K$11M+0.34%
Q4 202362.7K$10M+0.23%
Q3 202369.9K$10M+0.24%
Q2 2023159.0K$21M+0.36%
Q1 2023114.9K$18M+0.36%
Q4 2022111.4K$18M+0.39%
Q3 2022138.9K$19M+0.38%
Q2 2022122.7K$19M+0.37%
Q1 2022164.4K$27M+0.36%
Q4 2021151.6K$21M+0.26%
Q3 2021152.5K$16M+0.23%
Q2 2021146.1K$16M+0.24%
Q1 2021146.9K$16M+0.22%
Q4 2020144.5K$15M+0.22%
Q3 2020148.9K$13M+0.21%
Q2 2020147.1K$14M+0.25%
Q1 2020125.2K$10M+0.19%
Q4 2019240.3K$21M+0.28%
Q3 2019258.1K$20M+0.28%
Q2 2019252.4K$18M+0.28%
Q1 2019355.9K$29M+0.37%
Q4 2018352.6K$33M+0.45%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Norinchukin Bank, The’s full portfolio or all institutional holders of ABBV.